This balance appears to be weighted toward more inhibitory molecules during pregnancy in MS patients in the present study, as we find increased expression of CD274 (PDL1) and (PDCD1LG2) PDL2in monocytes. The gene discussed is CD274; the disease is myeloid sarcoma.